NEUP
Neuphoria Therapeutics Inc
NASDAQ: NEUP · HEALTHCARE · BIOTECHNOLOGY
$5.27
+1.54% today
Updated 2026-04-30
Market cap
$27.76M
P/E ratio
—
P/S ratio
1.85x
EPS (TTM)
$-0.69
Dividend yield
—
52W range
$4 – $21
Volume
0.1M
Neuphoria Therapeutics Inc (NEUP) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $14.63M | $26.14M | $27.09M | $19.95M | $26.78M | $36.67M | $31.83M | $48.93M | $61.25M | $53.02M | $65.72M | $64.61M | $47.80M | $37.58M | $23.68M | $40.77M | $44.93M | $19.39M | $27.65M | $28.59B |
| Cash & equivalents | $3.51M | $10.87M | $6.01M | $3.84M | $10.72M | $17.16M | $17.74M | $20.49M | $9.89M | $20.37M | $33.94M | $32.95M | $18.31M | $9.79M | $3.15M | $21.41M | $23.09M | $8.06M | $12.61M | $14.21B |
| Current assets | $3.83M | $11.84M | $8.47M | $4.75M | $11.81M | $26.60M | $22.25M | $28.03M | $37.21M | $29.05M | $43.38M | $41.86M | $26.39M | $17.60M | $5.73M | $23.24M | $28.76M | $8.87M | $13.19M | $15.04B |
| Total liabilities | $6.51M | $6.89M | $6.49M | $4.87M | $5.14M | $6.00M | $5.32M | $11.14M | $19.06M | $28.51M | $34.04M | $33.52M | $35.34M | $25.18M | $14.97M | $5.01M | $5.78M | $4.74M | $10.16M | $9.59B |
| Current liabilities | $1.99M | $3.06M | $2.92M | $2.25M | $2.75M | $5.86M | $4.57M | $5.55M | $8.74M | $10.51M | $8.50M | $10.67M | $9.76M | $9.67M | $5.68M | $1.77M | $2.31M | $1.82M | $3.83M | $4.22B |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shareholder equity | $8.12M | $19.25M | $20.60M | $15.09M | $21.64M | $30.67M | $26.51M | $37.79M | $42.20M | $24.52M | $31.69M | $31.09M | $12.46M | $12.39M | $8.71M | $35.76M | $39.15M | $14.65M | $17.49M | $19.00B |
| Retained earnings | $-20.43M | $-27.97M | $-36.13M | $-36.01M | $-44.90M | $-63.79M | $-64.29M | $-66.46M | $-65.54M | $-66.40M | $-77.05M | $-83.14M | $-96.49M | $-98.65M | $-102.30M | $-115.74M | $-119.22M | $-108.16M | $-177.98M | $-178.35B |
| Accounts receivable | $179837.00 | $287630.00 | $2.21M | $625818.00 | $719928.00 | $9.03M | $421042.00 | $644042.00 | $19.53M | $815843.00 | $8.22M | $7.60M | $523501.00 | $621017.00 | $40739.00 | $192885.00 | $4.67M | $283624.00 | $126884.00 | $11.95M |
| Inventory | $33274.00 | $84273.00 | $76024.00 | $98782.00 | $96099.00 | $45578.00 | $138448.00 | $89914.00 | $78542.00 | $314386.00 | $327729.00 | $327161.00 | $360016.00 | $465403.00 | $1.00 | $2.00 | $1.00 | — | — | — |
| Goodwill | $1.62M | $1.80M | $4.93M | $4.15M | $4.38M | $5.50M | $5.27M | $4.70M | $8.93M | $8.04M | $7.95M | $9.42M | $9.16M | $8.94M | $8.84M | $9.32M | $8.85M | $5.79M | $8.69M | $8.64B |